Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients

J Rheumatol. 2015 Oct;42(10):1993-4. doi: 10.3899/jrheum.150230.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Immunoconjugates / administration & dosage*
  • Male

Substances

  • Antirheumatic Agents
  • Immunoconjugates